{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:26:03Z","timestamp":1783070763904,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ajog.2013.12.036","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T18:00:10Z","timestamp":1388772010000},"page":"561.e1-561.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women"],"prefix":"10.1016","volume":"210","author":[{"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oidda I.","family":"Museru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manette","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.12.036_bib1","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"10.1016\/j.ajog.2013.12.036_bib2","first-page":"806","article-title":"Notice to readers: FDA approval for a combined hepatitis A and B vaccine","volume":"50","year":"2001","journal-title":"MMWR"},{"key":"10.1016\/j.ajog.2013.12.036_bib3","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Kroger","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2013.12.036_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0020-7292(87)90289-X","article-title":"Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants","volume":"25","author":"Ayoola","year":"1987","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2013.12.036_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-999384","article-title":"Hepatitis B vaccine in pregnancy: maternal and fetal safety","volume":"8","author":"Levy","year":"1991","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2013.12.036_bib6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/AOG.0b013e3182148efe","article-title":"Efficacy of an accelerated hepatitis B vaccination program during pregnancy","volume":"117","author":"Sheffield","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.12.036_bib7","unstructured":"GlaxoSmithKline Pregnancy Registries. Twinrix pregnancy registry for twinrix hepatitis A and hepatitis B (recombinant) vaccine. Available at: http:\/\/pregnancyregistry.gsk.com\/twinrix.html. Accessed July 19,\u00a02013."},{"key":"10.1016\/j.ajog.2013.12.036_bib8","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/S0264-410X(99)00132-2","article-title":"An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group","volume":"17","author":"Singleton","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.ajog.2013.12.036_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajog.2013.12.036_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The Vaccine Adverse Event Reporting System (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.ajog.2013.12.036_bib11","unstructured":"U.S. Department of Health and Human Services. VAERS table of reportable events following vaccination. Available at: http:\/\/vaers.hhs.gov\/resources\/VAERS_Table_of_Reportable_Events_Following_Vaccination.pdf. Accessed Nov. 19,\u00a02013."},{"key":"10.1016\/j.ajog.2013.12.036_bib12","unstructured":"U.S. Department of Health and Human Services. Vaccine Adverse Event Reporting System form. Available at: http:\/\/vaers.hhs.gov\/resources\/vaers_form.pdf. Accessed July 19,\u00a02013."},{"key":"10.1016\/j.ajog.2013.12.036_bib13","unstructured":"Medical dictionary for regulatory activities maintenance and support services organization. MedDRA; McLean, VA: 2010. Available at: http:\/\/www.meddra.org\/. Accessed July 19,\u00a02013."},{"key":"10.1016\/j.ajog.2013.12.036_bib14","unstructured":"Food and Drug Administration. 21 Code of Federal Regulation Part 600.80. Postmarketing reporting of adverse experiences. 1997;62:Federal Register: 52252-53. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=600.80. Accessed July 19,\u00a02013."},{"key":"10.1016\/j.ajog.2013.12.036_bib15","series-title":"Williams' obstetrics","first-page":"189","article-title":"Prenatal care","year":"2010"},{"key":"10.1016\/j.ajog.2013.12.036_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepid Drug Safety"},{"key":"10.1016\/j.ajog.2013.12.036_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pds.1107","article-title":"Comparing data mining methods on the VAERS database","volume":"14","author":"Banks","year":"2005","journal-title":"Pharmacoepid Drug Saf"},{"key":"10.1016\/j.ajog.2013.12.036_bib18","doi-asserted-by":"crossref","first-page":"146.e1","DOI":"10.1016\/j.ajog.2010.08.050","article-title":"Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009","volume":"204","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.12.036_bib19","doi-asserted-by":"crossref","first-page":"473.e1","DOI":"10.1016\/j.ajog.2011.06.047","article-title":"Adverse events in pregnant women following administration of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"205","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.12.036_bib20","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the\u00a0Advisory Committee on Immunization Practices (ACIP), 2009","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recommit Rep"},{"key":"10.1016\/j.ajog.2013.12.036_bib21","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2013.12.036_bib22","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2012.05.006","article-title":"Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women","volume":"207","author":"Zheteyeva","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.12.036_bib23","doi-asserted-by":"crossref","first-page":"c712","DOI":"10.1136\/bmj.c712","article-title":"Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials","volume":"340","author":"Wacholder","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2013.12.036_bib24","first-page":"1","article-title":"Fetal and perinatal mortality, United States, 2006","volume":"60","author":"MacDorman","year":"2012","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2013.12.036_bib25","first-page":"1","article-title":"Births: final data for 2010","volume":"61","author":"Martin","year":"2012","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2013.12.036_bib26","first-page":"CD002256","article-title":"Treatments for symptomatic urinary tract infections during pregnancy","author":"Vazquez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2013.12.036_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajmg.c.30319","article-title":"Amelia: a multi-center descriptive epidemiologic study in a large dataset from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature","volume":"157C","author":"Bermejo-S\u00e1nchez","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ajog.2013.12.036_bib28","first-page":"65","article-title":"Reporting birth defects surveillance data 1968-2003","volume":"79","author":"Correa","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813022473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813022473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:56:03Z","timestamp":1757588163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937813022473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0002937813022473"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.12.036","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}